Is Clinuvel Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Clinuvel Pharmaceuticals pays dividends. Last time was Monday 30th of September 2024 where the investors holding the stock on Monday 9th of September 2024 were paid $0.034 per share. Over the last 7 times between 2018 and 2024, Clinuvel Pharmaceuticals has paid $0.1601 with an average of $0.02 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Clinuvel Pharmaceuticals 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $20.28, you would have made a loss of $-11.52 per share or -56.80%
No, the average daily trading liquidity for Clinuvel Pharmaceuticals is $1 935 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Clinuvel Pharmaceuticals has no real debt, which is good in periods of high inflation. Clinuvel Pharmaceuticals has a very good net profit margin of 40.67% and should have very high tolerances against inflation.
We have calculated the inflation risk for Clinuvel Pharmaceuticals to be low [0.3 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.